236 related articles for article (PubMed ID: 18412394)
1. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
Abdelouahab N; Heard C
J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the relative antiinflammatory efficacies of six commercial preparations of Harpagophytum procumbens (Devil's Claw).
Ouitas NA; Heard C
Phytother Res; 2010 Mar; 24(3):333-8. PubMed ID: 19610038
[TBL] [Abstract][Full Text] [Related]
3. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
Romiti N; Tramonti G; Corti A; Chieli E
Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
[TBL] [Abstract][Full Text] [Related]
4. A new iridoid diglucoside from Harpagophytum procumbens.
Tomassini L; Serafini M; Foddai S; Ventrone A; Nicoletti M
Nat Prod Res; 2016; 30(2):157-61. PubMed ID: 26119468
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects.
Kaszkin M; Beck KF; Koch E; Erdelmeier C; Kusch S; Pfeilschifter J; Loew D
Phytomedicine; 2004 Nov; 11(7-8):585-95. PubMed ID: 15636171
[TBL] [Abstract][Full Text] [Related]
6. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay.
Anauate MC; Torres LM; de Mello SB
Phytother Res; 2010 Sep; 24(9):1365-9. PubMed ID: 20812280
[TBL] [Abstract][Full Text] [Related]
7. Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw).
Qi J; Chen JJ; Cheng ZH; Zhou JH; Yu BY; Qiu SX
Phytochemistry; 2006 Jul; 67(13):1372-7. PubMed ID: 16857222
[TBL] [Abstract][Full Text] [Related]
8. Harpagoside Content in Devil's Claw Extracts.
Kondamudi N; Turner MW; McDougal OM
Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
[TBL] [Abstract][Full Text] [Related]
9. The interaction potential of herbal medicinal products: a luminescence-based screening platform assessing effects on cytochrome P450 and its use with devil's claw (Harpagophyti radix) preparations.
Modarai M; Suter A; Kortenkamp A; Heinrich M
J Pharm Pharmacol; 2011 Mar; 63(3):429-38. PubMed ID: 21749392
[TBL] [Abstract][Full Text] [Related]
10. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.
Mncwangi N; Chen W; Vermaak I; Viljoen AM; Gericke N
J Ethnopharmacol; 2012 Oct; 143(3):755-71. PubMed ID: 22940241
[TBL] [Abstract][Full Text] [Related]
11. Itosides J-N from Itoa orientalis and structure - anti-COX-2 activity relationship of phenolic glycosides.
Chai XY; Song YL; Xu ZR; Shi HM; Bai CC; Bi D; Wen J; Li FF; Tu PF
J Nat Prod; 2008 May; 71(5):814-9. PubMed ID: 18412396
[TBL] [Abstract][Full Text] [Related]
12. What the devil is in your phytomedicine? Exploring species substitution in Harpagophytum through chemometric modeling of 1H-NMR and UHPLC-MS datasets.
Mncwangi NP; Viljoen AM; Zhao J; Vermaak I; Chen W; Khan I
Phytochemistry; 2014 Oct; 106():104-115. PubMed ID: 25041697
[TBL] [Abstract][Full Text] [Related]
13. Harpagoside: from Kalahari Desert to pharmacy shelf.
Georgiev MI; Ivanovska N; Alipieva K; Dimitrova P; Verpoorte R
Phytochemistry; 2013 Aug; 92():8-15. PubMed ID: 23642455
[TBL] [Abstract][Full Text] [Related]
14. The Fight against Infection and Pain: Devil's Claw (
Gxaba N; Manganyi MC
Molecules; 2022 Jun; 27(11):. PubMed ID: 35684573
[No Abstract] [Full Text] [Related]
15. Inhibitory effects of devil's claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages.
Inaba K; Murata K; Naruto S; Matsuda H
J Nat Med; 2010 Apr; 64(2):219-22. PubMed ID: 20177800
[TBL] [Abstract][Full Text] [Related]
16. A novel ex vivo skin model for the assessment of the potential transcutaneous anti-inflammatory effect of topically applied Harpagophytum procumbens extract.
Ouitas NA; Heard CM
Int J Pharm; 2009 Jul; 376(1-2):63-8. PubMed ID: 19383533
[TBL] [Abstract][Full Text] [Related]
17. Dermal and transcutaneous delivery of the major glycoside constituents of Harpagophytum procumbens (Devil's Claw) in vitro.
Abdelouahab N; Heard CM
Planta Med; 2008 Apr; 74(5):527-31. PubMed ID: 18401847
[TBL] [Abstract][Full Text] [Related]
18. Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix.
Hostanska K; Melzer J; Rostock M; Suter A; Saller R
J Pharm Pharmacol; 2014 Nov; 66(11):1606-14. PubMed ID: 25175765
[TBL] [Abstract][Full Text] [Related]
19. Rapid measurement and evaluation of the effect of drying conditions on harpagoside content in Harpagophytum procumbens (devil's claw) root.
Joubert E; Manley M; Gray BR; Schulz H
J Agric Food Chem; 2005 May; 53(9):3493-502. PubMed ID: 15853393
[TBL] [Abstract][Full Text] [Related]
20. Formation of nitrogen-containing metabolites from the main iridoids of Harpagophytum procumbens and H. zeyheri by human intestinal bacteria.
Baghdikian B; Guiraud-Dauriac H; Ollivier E; N'Guyen A; Dumenil G; Balansard G
Planta Med; 1999 Mar; 65(2):164-6. PubMed ID: 10193209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
